SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.78%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$318M
AUM Growth
+$318M
(-44%)
Cap. Flow
-$316M
Cap. Flow
% of AUM
-99.43%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
82
New
14
Increased
12
Reduced
20
Closed
21
Top Buys
| 1 |
Astria Therapeutics
ATXS
|
$6.99M |
| 2 |
FIVE9
FIVN
|
$6.45M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$5.81M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$5.05M |
| 5 |
Generac Holdings
GNRC
|
$5.03M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$43.1M |
| 2 |
AstraZeneca
AZN
|
$33.7M |
| 3 |
Sanofi
SNY
|
$31.7M |
| 4 |
Novo Nordisk
NVO
|
$30.4M |
| 5 |
Merck
MRK
|
$27.3M |
Sector Composition
| 1 | Healthcare | 88.5% |
| 2 | Technology | 3.25% |
| 3 | Industrials | 2.93% |
| 4 | Communication Services | 0.13% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
76
Verona Pharma
VRNA
$9.16B
| – | – | -120,000 | Closed | -$1.23M |
|
77
WIX.com
WIX
$7.85B
| – | – | -129,000 | Closed | -$10.1M |
|
|
PSTX
78
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – | -300,000 | Closed | -$1.06M |
|
|
DICE
79
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – | -152,913 | Closed | -$3.1M |
|